A Relationship between the Obstructive Sleep Apnea Syndrome and the Erythrocyte Sedimentation Rate
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. The erythrocyte sedimentation rate (ESR) is a marker for inflammation, and it has been identified as a risk factor for atherothrombotic cardiovascular disease. The aim of this study was to determine the relationship between the plasma ESR level and nocturnal oxygen desaturation or other polysomnographic variables and to examine the role of obesity in patients with obstructive sleep apnea syndrome (OSAS). Methods. This retrospective study included 72 patients with a diagnosis of OSAS who underwent overnight polysomnography and routine blood tests between July and December of 2005. We compared the plasma ESR level with the sum of all the polysomnographic variables and divided the patient group into obese and non-obese patients. Results. The mean ESR level was 8.45 mm/hr. There was a significant difference in the ESR level between genders (P<0.001). A significant correlation was found between the percentage of time spent at a SpO2 below 90% and the ESR level in the obese group (BMI ≥25, N=43, P=0.012). In addition, the ESR levels had a positive correlation with age in the obese group (P=0.002). However, there was no significant correlation with the percentage of time spent at a SpO2 below 90% in the whole group of patients and in the non-obese group (BMI <25, N=29). The ESR level showed no correlation with the other polysomnographic variables. Conclusion. The duration of deoxygenation in obese patients with OSAS may be associated with the ESR level which is an independent predictor of cardiovascular disease.
Abstract
Objectives. The erythrocyte sedimentation rate (ESR) is a marker for inflammation, and it has been identified as a risk factor for atherothrombotic cardiovascular disease. The aim of this study was to determine the relationship between the plasma ESR level and nocturnal oxygen desaturation or other polysomnographic variables and to examine the role of obesity in patients with obstructive sleep apnea syndrome (OSAS). Methods. This retrospective study included 72 patients with a diagnosis of OSAS who underwent overnight polysomnography and routine blood tests between July and December of 2005. We compared the plasma ESR level with the sum of all the polysomnographic variables and divided the patient group into obese and non-obese patients. Results. The mean ESR level was 8.45 mm/hr. There was a significant difference in the ESR level between genders (P<0.001). A significant correlation was found between the percentage of time spent at a SpO2 below 90% and the ESR level in the obese group (BMI ≥25, N=43, P=0.012). In addition, the ESR levels had a positive correlation with age in the obese group (P=0.002). However, there was no significant correlation with the percentage of time spent at a SpO2 below 90% in the whole group of patients and in the non-obese group (BMI <25, N=29). The ESR level showed no correlation with the other polysomnographic variables. Conclusion. The duration of deoxygenation in obese patients with OSAS may be associated with the ESR level which is an independent predictor of cardiovascular disease.
참고문헌 (26)
- Grote L, "Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension", J Hypertens, 18(6), pp.679~685 (2000)
- Kokturk O, "Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome", Int Heart J., 46(5), pp.801~809 (2005)
- Shahar E, "Sleep-disordered breathing and cardiovascular disease: crosssectional results of the Sleep Heart Health Study", Am J Respir Crit Care Med, 163(1), pp.19~25 (2001)
- Vgontzas AN, "Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity", J Clin Endocrinol Metab, 82(5), pp.1313~1316 (1997)
- Visser M, "Elevated C-reactive protein levels in overweight and obese adults", JAMA, 282(22), pp.2131~2135 (1999)
- Shamsuzzaman AS, "Obstructive sleep apnea:implications for cardiac and vascular disease", JAMA, 290(14), pp.1906~1914 (2003)
- Natali A, "Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality", Eur Heart J, 24(7), pp.639~648 (2003)
- Lowe GD, "Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease", J Thromb Haemost, 3(8), pp.1618~1627 (2005)
- Yokoe T, "Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure", Circulation, 107(8), pp.1129~1134 (2003)
- Andresdottir MB, "Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study", Am J Epidemiol, 158(9), pp.844~851 (2003)
- Timmer JR, "Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia", J Intern Med, 257(5), pp.423~429 (2005)
- Silvestrini M, "Carotid artery wall thickness in patients with obstructive sleep apnea syndrome", Stroke, 33(7), pp.1782~1785 (2002)
- Marin JM, "Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study", Lancet, 365(9464), pp.1046~1053 (2005)
- Dziewas R, "Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims", J Neurol, 252(11), pp.1394~1398 (2005)
- Good DC, "Sleep-disordered breathing and poor functional outcome after stroke", Stroke, 27(2), pp.252~259 (1996)
- Hermann DM, "Sleep-disordered breathing and stroke", Curr Opin Neurol, 16(1), pp.87~90 (2003)
- O’Leary DH, "Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group", Stroke, 23(12), pp.1752~1760 (1992)
- Wessendorf TE, "Sleep-disordered breathing among patients with first-ever stroke", J Neurol, 247(1), pp.41~47 (2000)
- Schulz R, "Changes in extracranial arteries in obstructive sleep apnoea", Eur Respir J, 25(1), pp.69~74 (2005)
- Festa A, "Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)", Circulation, 102(1), pp.42~47 (2000)
- Haverkate F, "Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group", Lancet, 349(9050), pp.462~466 (1997)
- Carlson LA, "Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focussing on the role of plasma triglycerides and cholesterol", Acta medica Scandinavica, 206(5), pp.351~360 (1979)
- Danesh J, "Association of fibrinogen, Creactive protein, albumin, or leukocyte count with coronary heart disease:meta-analyses of prospective studies", JAMA, 279(18), pp.1477~1482 (1998)
- Godsland IF, "Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study", Int J Cardiol, 97(3), pp.543~550 (2004)
- Nieto FJ, "Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study", JAMA, 283(14), pp.1829~1836 (2000)
- Hoffstein V, "Hematocrit levels in sleep apnea", Chest, 106(3), pp.787~791 (1994)